Skip to main content

Advertisement

Log in

Are Mastectomies on the Rise? A 13-Year Trend Analysis of the Selection of Mastectomy Versus Breast Conservation Therapy in 5865 Patients

  • Breast Oncology
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

The equivalency of survival between mastectomy and breast conservation therapy (BCT) has long been established, resulting in two decades of predominant BCT. Recently, surgeons have recognized a trend toward increasing mastectomy. Institutional trends of mastectomy and BCT were reviewed, confirming this perception in the surgical treatment of breast cancer. This report evaluates the factors that influence patient decisions to choose surgical therapies.

Methods

Patients who underwent mastectomy or BCT for invasive and in situ breast cancer were identified upon retrospective review of a prospectively accrued breast cancer database between 1994 and 2007. Univariate and multivariate logistic regression analysis were used to estimate the odds ratio (OR) of the association between mastectomy and patients’ clinicopathologic characteristics.

Results

Of the 5,865 patients, 3,736 underwent BCT and 2,129 underwent mastectomy. The overall surgical volume decreased during the study period. Mastectomy rates during the periods of 1994–1998, 1999–2003, and 2004–2007 were 33%, 33%, and 44%, respectively (P < 0.01). Immediate reconstruction rates decreased during the same time periods from 16%, 5%, and 7%, respectively (P < 0.01). On logistic regression analysis, gender, age < 40 years, increase tumor size, and lymphovascular invasion were significant independent predictors of mastectomy. The mastectomy rate increased during the period 1999–2003 (OR 1.2) and during 2004–2007(OR 1.8).

Conclusions

The perception of an increasing choice toward mastectomy has been confirmed at this institution. Possible reasons are younger population with higher lifetime risk, higher stage disease, and more biologically aggressive or diffuse tumors. Patient preference, fear of genetic or recurrence risk, and “intangible” factors seem to shift decisions toward mastectomy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Halsted WS. The results of radical operations for the cure of carcinoma of the breast. Ann Surg. 1907;46:1–19.

    Article  CAS  PubMed  Google Scholar 

  2. Fisher B, Anderson S, Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002;347:1233–41.

    Article  PubMed  Google Scholar 

  3. Veronesi U, Cascinelli N, Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002;347:1227–32.

    Article  PubMed  Google Scholar 

  4. Jacobson JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332:907–11.

    Article  CAS  PubMed  Google Scholar 

  5. Poggi MM, Danforth DN, Sciuto LC, et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer. 2003;98:697–702.

    Article  PubMed  Google Scholar 

  6. Arriagada R, Le MG, Guinebretiere JM, Dunant A, Rochard F, Tursz T. Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol. 2003;14:1617–22.

    Article  CAS  PubMed  Google Scholar 

  7. Mameri C, Kemp C, Goldman S, Sobral L, Ajzen S. Impact of breast MRI on surgical treatment, axillary approach, and systemic therapy for breast cancer. Breast J. 2008;14:236–44.

    Article  PubMed  Google Scholar 

  8. Bagley FH. The role of magnetic resonance imaging mammography in the surgical management of the index breast cancer. Arch Surg. 2004;139:380–3.

    Article  PubMed  Google Scholar 

  9. Bilimoria KY, Cambic A, Hansen NM, Bethke KP. Evaluating the impact of preoperative breast magnetic resonance imaging on the surgical management of newly diagnosed breast cancers. Arch Surg. 2007;142:441–7.

    Article  PubMed  Google Scholar 

  10. Bedrosian I, Mick R, Orel SG, et al. Changes in the surgical management of patients with breast carcinoma based on preoperative magnetic resonance imaging. Cancer. 2003;98:468–73.

    Article  PubMed  Google Scholar 

  11. Schelfout K, Van Goethem M, Kersschot E, et al. Contrast-enhanced MR imaging of breast lesions and effect on treatment. Eur J Surg Oncol. 2004;30:501–7.

    Article  CAS  PubMed  Google Scholar 

  12. Chan A, Pintilie M, Vallis K, Girourd C, Goss P. Breast cancer in women ≤35 years: review of 1002 cases from a single institution. Ann Oncol. 2000;11:1255–62.

    Article  CAS  PubMed  Google Scholar 

  13. Graves K, Peshkin B, Halbert C, DeMarco T, Isaacs C, Schwartz M. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors. Breast Cancer Res Treat. 2007;104:321–9.

    Article  PubMed  Google Scholar 

  14. Tuttle TM. Counseling breast cancer patients on contralateral prophylactic mastectomy: the physician’s role. Oncology (Williston Park). 2008;22:545–8.

    Google Scholar 

  15. Wood WC. Increasing use of contralateral prophylactic mastectomy: a counterintuitive trend. Oncology (Williston Park). 2008;22:548–51.

    Google Scholar 

  16. Hiotis K, Ye W, Sposto R, Skinner KA. Predictors of breast conservation therapy. Cancer. 2005;103:892–9.

    Article  PubMed  Google Scholar 

  17. Chagpar AB, Studts JL, Scoggins CR, et al. Factors associated with surgical options for breast carcinoma. Cancer. 2006;106:1462–6.

    Article  PubMed  Google Scholar 

  18. Neff PT, Bear HD, Pierce CV, et al. Long-term results of breast conservation therapy for breast cancer. Ann Surg. 1996;223:709–17.

    Article  CAS  PubMed  Google Scholar 

  19. Schwartz GF, Veronesi U, Clough KB, et al. Proceedings of the consensus conference on breast conservation, April 28 to May 1, 2005, Milan, Italy. Cancer. 2006;107:242–50.

    Article  PubMed  Google Scholar 

  20. McCahill LE, Privette AR, Hart MR, James TA. Are mastectomy rates a reasonable quality measure of breast cancer surgery? Am J Surg. 2009;197:216–21

    Article  PubMed  Google Scholar 

  21. Fancher TT, Palesty JA, Thomas R, et al. A woman’s influence to choose mastectomy as treatment for breast cancer. J Surg Res. 2009;153:128–31.

    Article  PubMed  Google Scholar 

  22. Tate PS, McGee EM, Hopkins SF, Rogers EL, Page GV. Breast conservation versus mastectomy: patient preferences in a community practice in Kentucky. J Surg Oncol. 1993;52:213–6.

    Article  CAS  PubMed  Google Scholar 

  23. Cohen L, Hack TF, de Moor C, Katz J, Goss PE. The effects of type of surgery and time on psychological adjustment in women after breast cancer treatment. Ann Surg Oncol. 2000;7:427–34.

    Article  CAS  PubMed  Google Scholar 

  24. van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy. European Organization for Research and Treatment of Cancer 10801 Trial. J Natl Cancer Inst. 2000;92:1143–50.

    Article  PubMed  Google Scholar 

  25. Yeatman TJ, Lyman GH, Smith SK, Reintgen DS, Cantor AB, Cox CE. Bilaterality and recurrence rates for lobular breast cancer: considerations for treatment. Ann Surg Oncol. 1997;4:198–202.

    Article  CAS  PubMed  Google Scholar 

  26. Silverstein MJ, Lewinsky BS, Waisman JR, et al. Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer. 1994;73:1673–7.

    Article  CAS  PubMed  Google Scholar 

  27. Moore MM, Borossa G, Imbrie JZ, et al. Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservation therapy. Ann Surg. 2000;231:877–82.

    Article  CAS  PubMed  Google Scholar 

  28. Furman B, Gardner MS, Romilly P, et al. Effect of 0.5 Tesla magnetic resonance imaging on the surgical management of breast cancer patients. Am J Surg. 2003;186:344–7.

    Article  PubMed  Google Scholar 

  29. Pediconi F, Catalano C, Padula S, et al. Contrast-enhanced magnetic resonance mammography: does it affect surgical decision-making in patients with breast cancer? Breast Cancer Res Treat. 2007;106:65–74.

    Article  PubMed  Google Scholar 

  30. Fischer U, Kopka L, Grabbe E. Breast carcinoma: effect of preoperative contrast-enhanced MR imaging on the therapeutic approach. Radiology. 1999;213:881–8.

    CAS  PubMed  Google Scholar 

  31. Katipamula R, Hoskin TL, Boughey JC, et al. Trends in mastectomy rates at the Mayo Clinic Rochester: effect of surgical year and preoperative MRI. J Clin Oncol. (Meeting Abstracts) 2008;26(15 Suppl):509.

    Google Scholar 

  32. Lee M, Rogers K, Griffith K, et al. Determinants of breast conservation rates: reasons for mastectomy at a comprehensive cancer center. Breast J. 2009;15:34–40.

    Article  PubMed  Google Scholar 

  33. Katz SJ, Lantz PM, Janz NK, et al. Patient involvement in surgery treatment decisions for breast cancer. J Clin Oncol. 2005;23:5526–33.

    Article  PubMed  Google Scholar 

  34. Rowland JH, Desmond KA, Meyerowitz BE, Belin TR, Wyatt GE, Ganz PA. Role of breast reconstructive surgery in physical and emotional outcomes among breast cancer survivors. J Natl Cancer Inst. 2000;92:1422–9.

    Article  CAS  PubMed  Google Scholar 

  35. Li BDL, Brown WA, Ampil FL, Burton GV, Yu HMD, McDonald JC. Patient compliance is critical for equivalent clinical outcomes for breast cancer treated by breast-conservation therapy. Ann Surg. 2000;231:883–9.

    Article  CAS  PubMed  Google Scholar 

  36. Lazovich D, Solomon CC, Thomas DB, Moe RE, White E. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma. Cancer. 1999;86:628-37.

    Article  CAS  PubMed  Google Scholar 

  37. Crowe J, Patrick R, Rim A. The importance of preoperative breast MRI for patients newly diagnosed with breast cancer. Breast J. 2009;15(1):52–60.

    Article  PubMed  Google Scholar 

  38. Gatzemeier W, Liersch T, Stylianou A, Buttler A, Becker H, Fischer U. Präoperative MR-Mammographie beim Mammacarcinom Einfluß auf die operative Behandlung aus chirurgischer Sicht. Der Chirurg. 1999;70(12):1460–8.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Charles E. Cox MD, FACS.

Rights and permissions

Reprints and permissions

About this article

Cite this article

McGuire, K.P., Santillan, A.A., Kaur, P. et al. Are Mastectomies on the Rise? A 13-Year Trend Analysis of the Selection of Mastectomy Versus Breast Conservation Therapy in 5865 Patients. Ann Surg Oncol 16, 2682–2690 (2009). https://doi.org/10.1245/s10434-009-0635-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-009-0635-x

Keywords

Navigation